Showing results (1101-1110 of 1,309) with videos related to

Sort By:
Pageof 131
Journal of Cancer Research and Clinical Oncology|October 4, 2016
L1CAM: amending the "low-risk" category in endometrial carcinomaFelix Kommoss, Friedrich Kommoss, Friederike Grevenkamp, et al.
Scientific Reports|March 3, 2021
COVID-19 salivary Raman fingerprint: innovative approach for the detection of current and past SARS-CoV-2 infectionsC Carlomagno, D Bertazioli, A Gualerzi, et al.
Medicina|June 22, 2026
[Hypertrophic cardiomyopathy and implantable cardiodefibrillator: 25 years of follow up]Jorge A Lax, Agustín Morales Pieruzzini, Carlos D Labadet, et al.
Gynecologic Oncology|March 3, 2020
Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumorsHelmut Plett, Philipp Harter, Beyhan Ataseven, et al.
Echocardiography (Mount Kisco, N.Y.)|July 21, 2020
Clinical significance of tissue Doppler imaging in chronic Chagas diseaseTomás F Cianciulli, María C Saccheri, Alonso Papantoniou, et al.
Forensic Science International|June 20, 2020
Detecting personal microbiota signatures at artificial crime scenesJarrad T Hampton-Marcell, Peter Larsen, Tifani Anton, et al.
Immunology|April 7, 2011
The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferationDebbie L Hardie, Mathew J Baldwin, Amy Naylor, et al.
Virchows Archiv : an International Journal of Pathology|February 6, 2022
Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter studySonia Gatius, Ana Velasco, Mar Varela, et al.
Virchows Archiv : an International Journal of Pathology|August 28, 2024
ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entityAbbas Agaimy, Josephine K Dermawan, Florian Haller, et al.
BJC Reports|September 2, 2024
Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancerAnthony Kong, Amanda J Kirkham, Joshua S Savage, et al.
Pageof 131